Diurnal IOP curves have limited value in patients with POAG

Article

Diurnal IOP curves have limited value in clinical practice for patients with primary open-angle glaucoma (POAG), according to a newly published study.

Diurnal IOP curves have limited value in clinical practice for patients with primary open-angle glaucoma (POAG), according to a study newly published in Ophthalmology. A single curve poorly characterizes fluctuations in IOP, and patterns cannot be reproduced from month to month, researchers say.

French researchers conducted a database study of 92 patients who had POAG. The patients had their diurnal IOP curve measurements taken 4 times, 6 months apart. Goldmann applanation tonometry had been recorded with patients in the sitting position at 9 am, 10 am, 11 am, noon, 2 pm, 3 pm, 4 pm and 5 pm. Intraclass correlation coefficients (ICCs) were used to measure intervisit agreement of IOP by time point and of diurnal IOP curve parameters, including mean, standard deviation, range, maximum, maximum hour, minimum and minimum hour.

The researchers found generally poor agreement of between-visit agreement of IOP values at each time point. ICCs were 0.26 to 0.77 in all patients. Also, using the first diurnal IOP curve to predict the risk of IOP fluctuations during the 3 subsequent curves was of limited value. "Only 6.4% of the patients with an IOP range ≥30% of the mean IOP on the first curve presented similar fluctuations on the 3 subsequent curves; 77.1% of the patients who did not have an IOP range ≥30% of the mean IOP on the first curve had an IOP range ≥30% of the mean IOP on at least 1 of the 3 subsequent curves," they wrote.

To read an abstract of the study, click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.